No Data
No Data
CereVasc Announces Appointments of New Directors
CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, today announced the following...
Should You Think About Buying Insulet Corporation (NASDAQ:PODD) Now?
Today we're going to take a look at the well-established Insulet Corporation (NASDAQ:PODD). The company's stock led the NASDAQGS gainers with a relatively large price hike in the past couple of
Should You Be Impressed By Insulet Corporation's (NASDAQ:PODD) ROE?
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
Insulet (NASDAQ:PODD) has outperformed the market over the past 15 years by 12.41% on an annualized basis producing an average annual return of 25.12%. Currently, Insulet has a market capitalization
Glaukos Cut as Citi Reviews U.S. MedTechs
Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024
Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced plans to release its financial results for the